What is Nuedexta and Is It Available in the UK?
Nuedexta is a drug that is used to help people to manage emotional outbursts. It is often used to manage uncontrollable crying. Some individuals who suffer from MS benefit from taking Nuedexta, and the drug has been approved for use in the United States since 2010 but has taken longer to be approved in other parts of the world.
In the United Kingdom, Nuedexta was approved for use to treat certain MS symptoms in 2013, but it is a prescription only drug, and its use is limited to the treating of things like uncontrollable emotional outbursts in MS sufferers. Around ten percent of people who live with MS suffer from uncontrollable bouts of tears or laughter, which are disproportionate to the person’s real emotional state. The condition can be embarrassing, confusing and even distressing for both the sufferer and for the people who care for them or work with them.
The condition is known as Affective Release, and it is thought to be caused by the MS-related nerve damage that builds up over time. MS can damage the nerves in the brain that control both the way emotions form and the way they are regulated, which is what causes the disproportionate expression of emotion.
One difficulty surrounding Affective Release is that it makes it hard to tell when someone with MS is feeling troubled, and this means that real issues are not taken as seriously as they might be. Nuedexta helps to regulate the mood and the expression of emotion in people with MS, and this means that it is easier for those people to express difficulties and to get help when they need it.
Nuedexta can help individuals who have Affective Release, and the PseudoBulbar Affect because of other medical issues as well, but this is something where exploration is still occurring in the UK. In the United States, Nuedexta has been tested extensively, and it has been found that within one week of taking it, sufferers experience 44 percent fewer episodes of uncontrolled laughing or crying, and within 12 weeks, they experience 82 percent fewer episodes. Almost one-third of people who take the drug find that they completely stop experiencing events within the first two weeks of taking the drug.
Nuedexta is just one example of a new, life-changing drug that has come on the market in the last few years. Drugs like this need to be monitored carefully and extensively tested before they are released onto the market because there are so many risks associated with them. While Nuedexta is generally considered to be safe, the FDA and similar organisations in the UK, India, and Europe are concerned about making sure that drugs are as safe as possible. This safety measure means ensuring that they are not addictive and that they are not going to cause any lasting harm or interact with other medications. It takes many years to put a drug through that approval process.